Navigation Links
World Think Tank on Type 1 Diabetes Meets in Miami
Date:11/13/2007

Panel of experts to present latest science and findings via MEDIA

TELECONFERENCE

BETHESDA, Md., Nov. 13 /PRNewswire/ --

WHAT: On World Diabetes Day, November 14, leaders in type 1 diabetes

research will present their findings to the media via

teleconference. These scientists represent two international groups

of type 1 diabetes researchers meeting in Miami during the week of

November 14 to share their latest findings and plan future

research.

WHEN: November 14, 2007, 12:00 - 1:30 p.m. (EST)

Four experts will make 15-minute presentations, followed by a 30-

minute Q&A.

WHY: This media teleconference presents an outstanding opportunity for

you to get an update on exciting type 1 diabetes research and

advances, as you put together stories for your readers during

American Diabetes Month in November.

-- Type 1 diabetes is increasing every year, reaching epidemic

proportions in some countries, with the greatest increase in

children under age 5. In response to this phenomenon, diabetes

researchers across the globe have been working to advance the

study, prevention and treatment of type 1 diabetes. As a result,

the way we detect and treat diabetes is dramatically changing. A

simple blood test can now identify the autoantibodies for type 1

diabetes up to 10 years before diagnosis.

-- If diabetes can be delayed, even for a few years, those at risk may

be able to postpone the difficult challenges of controlling their

glucose levels and the development of serious complications. The

serious complications of diabetes include heart disease, stroke,

blindness, kidney damage and lower-limb amputations.

PANEL TOPICS & PRESENTERS:

Advances in the Prevention and Reversal of Type 1 Diabetes

Jay Skyler, MD, MACP, University of Miami

Chairman of Type 1 Diabetes TrialNet and Professor at the

internationally renowned University of Miami's Diabetes Metabolic

Unit, Dr. Skyler will give an overview of the current advances and

planned research efforts toward finding ways to prevent and reverse

type 1 diabetes.

Nasal Insulin and Prevention of Type 1 Diabetes

Olli Simell, MD, PhD, University of Turku, Finland

Physician, researcher, and instructor of international stature, Dr.

Simmel will provide an overview of a study testing nasal insulin to

prevent type 1 diabetes in children in Finland. Finland has the

highest incidence of type 1 diabetes in the world.

Adult Stem Cells and Reversal of Type 1 Diabetes

Massimo Trucco, MD, University of Pittsburgh

Hillman Professor of Pediatric Immunology and Division Director of

Immunogenetics at Children's Hospital of Pittsburgh, Dr. Trucco

will provide an update on the use of adult stem cells in the

reversal of type 1 diabetes. He will also talk about the critical

immunologic steps that lead to autoimmunity in type 1 diabetes and

the use of this information to prevent and possibly cure type 1

diabetes.

Umbilical Cord Infusion to Reduce Type 1 Severity and Reset

Immunity

Michael Haller, MD, University of Florida College of Medicine,

Gainesville

Dr. Haller, an innovative and proficient researcher of diabetes in

children, will share how cord blood is being tested to treat type 1

diabetes in children newly diagnosed with type 1 diabetes.

Preliminary results show that it appears to reduce disease

severity, possibly re-setting the immune system and slowing the

destruction of their insulin-producing cells.

ABOUT THE MEETINGS

The Type 1 Diabetes TrialNet Study Group

This group of type 1 diabetes experts will meet November 12-14 to discuss current and planned research around type 1 diabetes. Researchers at more than 150 medical centers in the U.S., Canada, Europe and Australia have joined this global network dedicated to study the prevention, early detection and treatment of type 1 diabetes. These centers are offering free screenings for relatives of people with type 1 diabetes, as well as clinical trials in prevention, early detection and early onset. Type 1 Diabetes TrialNet is supported by the National Institutes of Health (NIH), Juvenile Diabetes Research Foundation International, and the American Diabetes Association. To learn more about Type 1 Diabetes TrialNet, visit http://www.DiabetesTrialNet.org

The 9th International Congress of the Immunology of Diabetes Society (IDS) and American Diabetes Association (ADA) Research Symposium

International researchers will meet November 14-18 to discuss the latest science and theories in type 1 diabetes research. IDS is an international collaboration created to advance research in the etiology, pathogenesis, prevention and cure of type 1 diabetes. A key area of focus is clinical trials to alter the type 1 diabetes disease process, eventually leading to prevention of this disease. ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

TO REGISTER FOR THE MEDIA TELECONFERENCE:

Please contact:

Sarah Bakka

sbakka@mmgct.com

301.348.1685


'/>"/>
SOURCE TrialNet
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
Breaking Biology Technology:
(Date:10/4/2017)... BLOOMINGTON, Ill. , Oct. 4, 2017  GCE Solutions, a ... powerful new data and document anonymization solution on October 4, 2017. ... the pharmaceutical field to comply with policy 0070 of the European ... documents and data. ... Innovation by GCE Solutions ...
(Date:8/15/2017)... Aug. 15 2017   ivWatch LLC , a medical device ... therapy, today announced receipt of its ISO 13485 Certification, the global ... International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection of ... "This is an important milestone ...
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
Breaking Biology News(10 mins):